108 research outputs found

    Problema-experiencia para construir un modelo redox

    Get PDF
    En las aulas universitarias, existe una separaciĂłn muy comĂșn entre “teorĂ­a”, “trabajo experimental” y “problemas”. En este trabajo se analizan los resultados de una experiencia que busca integrar esas tres actividades. En la Facultad de Ciencias Veterinarias de la UNCPBA, en Tandil (Argentina), a un grupo de alumnos de primer año, se les propuso un problema a investigar. DebĂ­an armar un diseño experimental, ejecutarlo, comparar resultados, extraer inferencias de un hecho empĂ­rico, y aplicar conceptos de Ăłxido-reducciĂłn. Al comenzar la actividad se percibe el desconcierto de los estudiantes frente a esta problemĂĄtica inusual para ellos (diseñar un trabajo experimental), pero luego la realizan en forma cooperativa y con entusiasmo

    Anatomical variation of the palmaris longus muscle: finding in zone V flexor injury

    Get PDF
    The palmaris longus is a muscle located on the anterior surface of the forearm, known for its significant anatomical variability. This ranges from its absence, the most common variant, to having multiple insertions or muscular bellies. The aim of the study is to highlight the uncommon anatomical variant diagnosed as an incidental finding and to contribute to the statistics of this type of pathology in our country. A case is reported involving a 14-year-old patient with no significant medical history who sustained a cut injury. Surgical exploration through the previous wound was conducted by the plastic surgery department at the General Hospital of Mexico (2023). The incidental finding revealed complete laceration of both tendons of the palmaris longus muscle, prompting the repair of both tendons. The bifid palmaris longus is a rare anatomical anomaly, not previously described in the statistics of our country. Therefore, the significance of reporting this anatomical variant as an incidental finding is noteworthy

    Alternative approach to the optimality of the threshold strategy for spectrally negative Levy processes

    Full text link
    Consider the optimal dividend problem for an insurance company whose uncontrolled surplus precess evolves as a spectrally negative Levy process. We assume that dividends are paid to the shareholders according to admissible strategies whose dividend rate is bounded by a constant. The objective is to find a dividend policy so as to maximize the expected discounted value of dividends which are paid to the shareholders until the company is ruined. Kyprianou, Loeffen and Perez [28] have shown that a refraction strategy (also called threshold strategy) forms an optimal strategy under the condition that the Levy measure has a completely monotone density. In this paper, we propose an alternative approach to this optimal problem.Comment: 16 page

    Bioelectrical impedance phase angle in clinical practice: implications for prognosis in stage IIIB and IV non-small cell lung cancer

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>A frequent manifestation of advanced lung cancer is malnutrition, timely identification and treatment of which can lead to improved patient outcomes. Bioelectrical impedance analysis (BIA) is an easy-to-use and non-invasive technique to evaluate changes in body composition and nutritional status. We investigated the prognostic role of BIA-derived phase angle in advanced non-small cell lung cancer (NSCLC).</p> <p>Methods</p> <p>A case series of 165 stages IIIB and IV NSCLC patients treated at our center. The Kaplan Meier method was used to calculate survival. Cox proportional hazard models were constructed to evaluate the prognostic effect of phase angle, independent of stage at diagnosis and prior treatment history.</p> <p>Results</p> <p>93 were males and 72 females. 61 had stage IIIB disease at diagnosis while 104 had stage IV. The median phase angle was 5.3 degrees (range = 2.9 – 8). Patients with phase angle <= 5.3 had a median survival of 7.6 months (95% CI: 4.7 to 9.5; n = 81), while those with > 5.3 had 12.4 months (95% CI: 10.5 to 18.7; n = 84); (p = 0.02). After adjusting for age, stage at diagnosis and prior treatment history we found that every one degree increase in phase angle was associated with a relative risk of 0.79 (95% CI: 0.64 to 0.97, P = 0.02).</p> <p>Conclusion</p> <p>We found BIA-derived phase angle to be an independent prognostic indicator in patients with stage IIIB and IV NSCLC. Nutritional interventions targeted at improving phase angle could potentially lead to an improved survival in patients with advanced NSCLC.</p

    Bioelectrical impedance phase angle as a prognostic indicator in breast cancer

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Bioelectrical impedance analysis (BIA) is an easy-to-use, non-invasive, and reproducible technique to evaluate changes in body composition and nutritional status. Phase angle, determined by bioelectrical impedance analysis (BIA), detects changes in tissue electrical properties and has been hypothesized to be a marker of malnutrition. Since malnutrition can be found in patients with breast cancer, we investigated the prognostic role of phase angle in breast cancer.</p> <p>Methods</p> <p>We evaluated a case series of 259 histologically confirmed breast cancer patients treated at Cancer Treatment Centers of America. Kaplan Meier method was used to calculate survival. Cox proportional hazard models were constructed to evaluate the prognostic effect of phase angle independent of stage at diagnosis and prior treatment history. Survival was calculated as the time interval between the date of first patient visit to the hospital and the date of death from any cause or date of last contact/last known to be alive.</p> <p>Results</p> <p>Of 259 patients, 81 were newly diagnosed at our hospital while 178 had received prior treatment elsewhere. 56 had stage I disease at diagnosis, 110 had stage II, 46 had stage III and 34 had stage IV. The median age at diagnosis was 49 years (range 25 – 74 years). The median phase angle score was 5.6 (range = 1.5 – 8.9). Patients with phase angle <= 5.6 had a median survival of 23.1 months (95% CI: 14.2 to 31.9; n = 129), while those > 5.6 had 49.9 months (95% CI: 35.6 to 77.8; n = 130); the difference being statistically significant (p = 0.031). Multivariate Cox modeling, after adjusting for stage at diagnosis and prior treatment history found that every one unit increase in phase angle score was associated with a relative risk of 0.82 (95% CI: 0.68 to 0.99, P = 0.041). Stage at diagnosis (p = 0.006) and prior treatment history (p = 0.001) were also predictive of survival independent of each other and phase angle.</p> <p>Conclusion</p> <p>This study demonstrates that BIA-derived phase angle is an independent prognostic indicator in patients with breast cancer. Nutritional interventions targeted at improving phase angle could potentially lead to an improved survival in patients with breast cancer.</p
    • 

    corecore